Jupiter Neurosciences
(NASDAQ) JUNS
Jupiter Neurosciences Financials at a Glance
Market Cap
$13.73M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.60M
EPS (TTM)
$-0.23
P/E Ratio
-1.75
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$0.38
Volume
136,079
Open
$0.41
Price
$0.38
Volume
136,079
Open
$0.41
Previous Close
$0.38
Daily Range
$0.37 - $0.41
52-Week Range
$0.33 - $3.33
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$0.38
Volume
136,079
Open
$0.41
Previous Close
$0.38
Daily Range
$0.37 - $0.41
52-Week Range
$0.33 - $3.33
JUNS News
JUNS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jupiter Neurosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
Christer Rosén
Website
www.jupiterneurosciences.comHeadquarters
Jupiter, FL 33477, US
JUNS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-132%
Return on Assets
-3%
Earnings Yield
-57.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$13.73M
Shares Outstanding
34.43M
Volume
136.08K
Short Interest
0.00%
Avg. Volume
326.17K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$3.09M
EBITDA
$2.19M
Operating Cash Flow
$3.91M
Capital Expenditure
$4.00
Free Cash Flow
$3.91M
Cash & ST Invst.
$3.77M
Total Debt
$217.76K
Jupiter Neurosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$13.73M
N/A
Market Cap/Employee
$3.43M
N/A
Employees
4
N/A
Net Income
$2.29M
-287.1%
EBITDA
$2.29M
-372.8%
Quarterly Fundamentals
Net Cash
$543.40K
+123.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$180.39K
-91.8%
Return on Assets
-2.95%
N/A
Return on Invested Capital
-131.64%
N/A
Free Cash Flow
$1.15M
-2610.1%
Operating Cash Flow
$1.15M
-2610.1%